Clinical Scorecard: Frequency of Polycystic Ovary Syndrome in Adolescents Based on Different Diagnostic Criteria

At a Glance

Key Highlights

• Prevalence of PCOS in adolescents ranged from 46% to 59% depending on diagnostic criteria (Ibáñez, Peña, Rotterdam).
• Clinical hyperandrogenism (88.1%–91.5%) is more common than biochemical hyperandrogenism (54.9%–55.3%) in adolescents with PCOS.
• Oligomenorrhea (>45 days) is the most frequent menstrual abnormality; ovarian volume is consistently higher in PCOS patients across all definitions.

Guideline-Based Recommendations

Diagnosis

• Use adolescent-specific diagnostic criteria (Ibáñez or Peña) requiring menstrual irregularities plus clinical or biochemical hyperandrogenism to avoid overdiagnosis.
• Consider Rotterdam criteria cautiously in adolescents due to physiological overlap with normal puberty.
• Assess clinical signs of hyperandrogenism including hirsutism (mFG scale), acne, and alopecia.

Management

• Early and accurate diagnosis to enable timely preventive and therapeutic interventions.
• Monitor and address metabolic and reproductive complications associated with PCOS.

Monitoring & Follow-up

• Regular evaluation of menstrual cycle patterns and androgen levels (LH, total testosterone, androstenedione).
• Ultrasound assessment of ovarian volume and morphology.
• Clinical monitoring of hyperandrogenism signs such as hirsutism and acne.

Risks

• Potential for long-term metabolic and reproductive complications if PCOS is not diagnosed and managed early.
• Risk of overdiagnosis if adult criteria are applied without adolescent-specific considerations.

Patient & Prescribing Data

Adolescents presenting with hyperandrogenism and/or menstrual irregularities

Clinical signs predominate over biochemical markers; thus, treatment decisions should integrate clinical assessment with hormonal evaluation.

Clinical Best Practices

• Apply adolescent-specific diagnostic criteria to improve diagnostic accuracy and reduce overdiagnosis.
• Use detailed patient interviews to assess hirsutism when physical scoring is limited by prior hair removal.
• Recognize oligomenorrhea (>45 days) as a common menstrual abnormality in adolescent PCOS.
• Incorporate ultrasound measurement of ovarian volume as a supportive diagnostic tool.
• Prioritize clinical evaluation of hyperandrogenism signs such as acne and hirsutism in adolescents.

References

• Ibáñez et al. adolescent PCOS diagnostic criteria (2017)
• Peña et al. adolescent PCOS diagnostic criteria (2020)
• Rotterdam criteria for PCOS diagnosis